Novartis AG (ADR) (NYSE:NVS) announced that Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) has received a Breakthrough Therapy designation from the United States Food and Drug Administration (FDA). Novartis AG (ADR) (NYSE:NVS) shares after opening at $82.91 moved to $83.50 on last trade day and at the end of the day closed at $82.51. Company price to sales ratio in past twelve months was calculated as 3.84 and price to cash ratio as 24.85. Novartis AG (ADR) (NYSE:NVS) showed a positive weekly performance of 1.13%.
Citigroup Inc. reaffirmed their neutral rating on shares of AstraZeneca plc (NYSE:AZN) in a report released on Thursday, American Banking & Market News reports. Citigroup Inc. currently has a GBX 3,500 ($58.24) price objective on the stock. AstraZeneca plc (ADR) (NYSE:AZN) shares fell -0.95% in last trading session and ended the day on $64.42. AZN return on equity ratio is recorded as 19.10% and its return on assets is 8.10%. AstraZeneca plc (ADR) (NYSE:AZN) yearly performance is 34.54%.
Global Payments Inc. (NYSE:GPN), one of the largest worldwide providers of payment solutions, on 3 April announced results for its fiscal third quarter ended February 28, 2014. Global Payments Inc. (NYSE:GPN) shares moved down -4.69% in last trading session and was closed at $68.28, while trading in range of $67.95 – $70.25. Global Payments Inc. (NYSE:GPN) year to date (YTD) performance is 5.09%.
Hydrogenics Corporation (NASDAQ:HYGS) a leading developer and manufacturer of hydrogen generation and hydrogen-based power modules, on 4 April announced that customer-driven timing of deliveries have impacted revenue for the first quarter of 2014. Hydrogenics Corporation (USA) (NASDAQ:HYGS) weekly performance is -15.00%. On last trading day company shares ended up $23.75. Hydrogenics Corporation (USA) (NASDAQ:HYGS) distance from 50-day simple moving average (SMA50) is -9.02%. Analysts mean target price for the company is $34.50.
Leave a Reply